Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: June 2025 (Event date: June 9, 2025)
Context: The filing reports a significant intellectual property milestone rather than financial results. The Company announced the receipt of a Notice of Patent Allowance in the United States for a novel cryogen flow control technology designed to optimize patient outcomes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is an event-driven report and does not contain financial statements or performance metrics.
Material Changes
Intellectual Property: The Company received a Notice of Patent Allowance in the U.S. for a novel cryogen flow control system. This represents a material advancement in the Company's patent portfolio and potential competitive positioning.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release by reference, highlighting the strategic importance of the new patent for optimizing patient outcomes.
Guidance: The filing text does not provide a clear value for future financial guidance or operational outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text beyond the standard incorporation of the press release into existing registration statements.
Investor Verification Checklist
- Verify the specific scope and claims of the newly allowed U.S. patent for cryogen flow control.
- Confirm the timeline for commercializing the technology covered by the patent.
- Review the full text of the press release (Exhibit 99.1) for additional technical details not summarized in the Form 6-K.
- Check subsequent filings for any financial impact or revenue recognition related to this technology.